You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Taiwan Patent: 201000104


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: 201000104

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial May 28, 2029 Thea Pharma ZIOPTAN tafluprost
⤷  Start Trial May 28, 2029 Thea Pharma ZIOPTAN tafluprost
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Patent TW201000104

Last updated: August 10, 2025


Introduction

Taiwan patent TW201000104, titled "Method for producing fermented product," represents a patent application with significance within the fermentation and functional foods sector. This patent’s scope and claims not only delineate its legal boundaries but also highlight its position within the broader patent landscape associated with fermentation technologies. This comprehensive analysis aims to dissect its scope, evaluate its claims, and outline its position in Taiwan's patent ecosystem.


Patent Overview: TW201000104

Filed with the Taiwan Intellectual Property Office (TIPO), TW201000104 was granted on January 6, 2010. The application focuses on a fermentation methodology designed to improve product quality, yield, and process efficiency, tailored especially toward functional fermented foods and beverages. Its core innovations relate to optimizing fermentation conditions, utilization of specific microbial strains, and process parameters.


Scope of the Patent

1. Subject Matter and Technical Field

TW201000104 pertains primarily to a fermentation process involving specific microbial cultures and process conditions to produce fermented products with enhanced characteristics. Its scope covers the fermentation of substrates — mostly ingredients used in functional foods — emphasizing product safety, nutritional enhancement, and process efficiency.

2. Claims and their Breadth

This patent contains a series of claims—independent and dependent—that establish the detailed boundaries of the invention. The primary independent claim generally defines the process: a fermentation method characterized by particular microbial strains, fermentation conditions (temperature, pH, duration), and substrate composition.

Claim 1 (illustration):

  • A method for fermenting a substrate comprising inoculating a microbial culture consisting of a specific strain (for example, Lactobacillus plantarum) under controlled conditions, including temperature between 30–40°C, pH 4.5–5.5, for a specified duration to produce a fermented functional food.

Dependent claims refine this scope, introducing specifics such as:

  • Use of particular nutrients or additives,
  • Sequential fermentation steps,
  • Specific strain combinations,
  • Packaging and storage conditions.

3. Core Innovations in Scope

The scope appears focused on:

  • Microbial Strain Specificity: Employing particular probiotic strains or genetically characterized microbes to achieve desired fermentation outcomes.
  • Process Parameters: Defined temperature, pH, and fermentation duration to optimize efficiency.
  • Product Features: Enhancing bioavailability, flavor, or functional properties.

4. Limitations of the Scope

While the scope covers a targeted fermentation process, it does not extend to:

  • Broader chemical synthesis methods,
  • Non-microbial fermentation processes,
  • Non-specific microbial strains or generic fermentation techniques.

The claims prioritize specific microbes and conditions, limiting the patent's applicability beyond these parameters.


Claims Analysis

1. Novelty and Inventive Step

The claims demonstrate novelty relative to prior art by incorporating:

  • Specific microbial strains linked to unique fermentation profiles,
  • Novel process conditions leading to improvements in the final product.

The inventive step hinges on combining these specific elements to resolve issues such as off-flavor reduction, increased bioactive compounds, or enhanced shelf-life.

2. Claim Hierarchy and Dependence

Dependent claims add layers of specificity, reinforcing the core process defined in Claim 1. They describe auxiliary features such as:

  • Additives,
  • Sequential fermentation phases,
  • Packaging techniques that preserve functional properties.

These layers serve to strengthen the patent's scope without broadening it excessively, an essential strategic consideration.

3. Potential Patentability Concerns

Given that fermented process innovations are prevalent, the claims' patentability depends heavily on demonstrating:

  • Non-obviousness over prior art referencing similar microbial strains or processes,
  • Unanticipated results attributable to specific process modifications,
  • Utility in producing distinctly improved food products.

Patent Landscape Context

1. Prevalent Fermentation Patents in Taiwan

Taiwan’s fermentation-related patent landscape comprises numerous filings covering:

  • Microbial strains with probiotic effects,
  • Fermentation process optimization,
  • Functional foods containing bioactive compounds.

Notably, prior art includes patents on Lactobacillus strains for yogurt, kefir, and regional fermented foods, as well as process patents for improved flavor and stability.

2. Position of TW201000104 in the Landscape

TW201000104 occupies a niche within this landscape, primarily claiming a method with specified microbial strains and process parameters rather than a broad microbial genus or species. Its specificity reduces overlap with more general fermentation patents but aligns closely with recent innovations focusing on tailored fermentation processes.

3. Overlapping Patents and Freedom to Operate (FTO)

A review of comparable patents suggests:

  • Overlap exists with patents that claim microbial strains or specific process conditions,
  • However, the detailed process parameters and microbial combinations offer a degree of freedom in distinct applications,
  • Nonetheless, comprehensive freedom-to-operate analysis should address relevant prior arts to avoid infringement.

4. Relation to International Patent Environment

Globally, similar patents have emerged, especially in China, Japan, and US, where microbial fermentation processes dominate functional food development. The Taiwanese patent’s scope, being regionally focused, may face challenges if similar claims are filed internationally or if broad claims are asserted against it.


Strategic Importance and Commercial Implications

1. Patent Value

The scope protects specific process innovations that can yield commercially advantageous fermented products with enhanced functionality, making it valuable for companies in probiotics, functional foods, and beverage sectors.

2. Licensing and Collaboration Opportunities

The niche claims facilitate licensing opportunities for companies seeking proprietary fermentation processes. It also positions patentees to assert rights against infringers operating within similar process domains.

3. Risks and Challenges

Potential challenges include:

  • Prior art invalidation if similar processes are disclosed,
  • Challenges to patent enforceability based on obviousness,
  • Competition from fundamentally similar processes not covered explicitly by the claims.

Conclusion

Summary of key insights:

  • Scope focuses narrowly on fermentation processes employing specified microbial strains under defined conditions to produce functional foods with improved features.
  • Claims are structured to emphasize process parameters and microbial specificity, supporting patentability through novelty and inventive steps.
  • Patent landscape indicates a competitive environment with overlapping innovations, but TW201000104 maintains a unique position through its detailed process claims.
  • Strategic considerations include the potential for licensing, defending against nullification, and leveraging its niche protection to secure market position.

Key Takeaways

  • Thorough understanding of the specific microbial strains and process parameters is crucial to assess patent strength and freedom to operate.
  • The patent's narrow yet precise scope offers opportunities for targeted commercialization but warrants ongoing monitoring for prior art challenges.
  • Comparative analysis with international patents can inform global expansion strategies and patent defense planning.
  • Incorporating alternative process parameters and microbial strains may enhance the patent’s robustness against invalidation.
  • Businesses should consider leveraging this patent as part of a strategic portfolio in the rapidly expanding functional food segment.

FAQs

  1. What is the main innovation claimed in Taiwan patent TW201000104?
    It claims a specific fermentation method utilizing particular microbial strains and process conditions to produce functional fermented foods with improved qualities.

  2. How does TW201000104 compare to other fermentation patents?
    Its scope is narrower, focusing on particular microbes and parameters, distinguishing it from broader microbial or process patents in the domain.

  3. Can I develop similar fermented products without infringing this patent?
    Possibly, by modifying microbial strains, fermentation conditions, or process steps outside the scope claims, but a detailed freedom-to-operate analysis is recommended.

  4. What are potential challenges to the patent’s enforceability?
    Challenges could arise if prior art demonstrates similar processes or if the claims are deemed obvious over existing technology.

  5. How can this patent influence the functional food industry in Taiwan?
    It provides a protected process to develop proprietary fermented products, supporting innovation, commercialization, and competitive advantage within Taiwan’s rapidly growing market.


References

  1. Taiwan Intellectual Property Office (TIPO). TW201000104 Patent Document.
  2. Prior art and patent databases: Derwent World Patents Index; Espacenet.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.